HLN: Haleon Group P/S multiplikatori

Haleon Group (HLN) kompaniyasining korporativ logotipi

Mashhur brendlarga bo'lgan yuqori sodiqlik mijozlar oqimining barqarorligini kafolatlaydi, buni Haleon plc (HLN) uchun P/S grafigi tasdiqlaydi. 2.70 qiymati ushbu ko'rsatkichning darajasini anglatadi va biznes qiymatini daromad bilan bog'laydi. Haleon plc iste'molchi sog'liqni saqlash sohasidagi global yetakchiligi hamda Sensodyne va Theraflu brendlarining tanilganligidan foydalangan holda OTC segmentida ustunlik qilmoqda.

Haleon Group - HLN P/S multiplikatori (davr: 28.04.2023 - 14.11.2026)

Haleon (HLN) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Narxlar dinamikasi grafigi Haleon|HLN - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi haqida ma'lumot:
Bozor kapitallashuvi Haleon|HLN - Kompaniyaning to‘liq qiymati
- balans bo'yicha xususiy kapital ma'lumotlari:
Bitta aksiya uchun sof aktivlar Haleon|HLN - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti haleon.com|HLN - Kompaniyaning jami aktivlari
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Haleon plc|HLN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Haleon|HLN - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Haleon|HLN - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Haleon|Tezkor likvidlik haleon.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
HLN - Sof foyda|Kelajakdagi foyda Haleon plc|HLN - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori Haleon Corp|HLN - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Haleon|HLN - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun foyda Haleon|HLN - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik dinamikasi haleon.com|HLN - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Haleon plc
- emitentning tushumi va sotuvlari tafsilotlari:
HLN - Daromad va sotish hajmi|Prognoz qilingan sotish hajmi Haleon PLC|HLN - Narxning daromadga nisbati|Sotuvga nisbatan forvard narx Haleon
Kompaniyaning jamlanma tahliliyoti:Haleon PLC, HLN
haleon.com seriyali mahsuloti

P/S koeffitsienti Haleon plc (HLN) bozor qiymatini uning savdo hajmi bilan solishtiradi, bu esa generatsiya qilingan pul oqimiga nisbatan biznes uchun qanchalik ortiqcha to'lov qilinganini aniqlash imkonini beradi. Savdo hajmi va narx nisbatini tahlil qilish orqali investor narxlarning haddan tashqari oshganini o'z vaqtida aniqlay oladi, bu esa iste'molchilar sodiqligi yuqori bo'lgan global sog'liqni saqlash gigantiga sarmoya kiritishda kapitalni saqlab qolish uchun juda muhimdir.

Haleon plc raqobatchilari

KVUE (Kenvue Inc) - Bozor kapitallashuvining daromadga nisbati|Verona Pharma Corp - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati MENS (Jyong Biotech Ltd)|ligand.com - P/S multiplikatori|amneal.com (AMRX) - Kapitalizatsiyaning daromadga nisbati|Perrigo (PRGO) - Narxning daromadga nisbati|ALVO (Alvotech S.A.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati LQDA|P/S multiplikatori Galapagos Corp|Narxning daromadga nisbati ANI Pharma (ANIP)|P/S multiplikatori MannKind Corporation (MNKD)|Narxning daromadga nisbati Amphastar Pharmaceuticals Inc AMPH|P/S multiplikatori Pacira PCRX|ARS Pharmaceuticals Inc - P/S multiplikatori|TBPH - P/S multiplikatori|AQST (Aquestive Therapeutics) - Kapitalizatsiyaning daromadga nisbati|scPharmaceuticals, Inc. (SCPH) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati TECX|P/S multiplikatori Tonix Pharma|Kapitalizatsiyaning daromadga nisbati SXTC (SXT Pharmaceuticals)|EPRX: Narxning sotuvga nisbati|BioHarvest Sciences - Kapitalizatsiyaning daromadga nisbati|EXOZ: Kapitalizatsiya va daromad nisbati|ORMP - Narxning daromadga nisbati|ENTX: Narxning daromadga nisbati|HYFT: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati ABVC BioPharma Inc|CPIX (Cumberland Corp) - P/S multiplikatori|P/S multiplikatori quantumbiopharma.com|P/S multiplikatori FGEN|Kapitalizatsiyaning daromadga nisbati Telomir Pharmaceuticals, Inc. TELO|P/S multiplikatori RANI (Rani Therapeutics)|SNYR (Synergy CHC Corp) - Narxning sotuvga nisbati|RLYB: Kapitalizatsiyaning daromadga nisbati|lexariabioscience.com (LEXX) - Kapitalizatsiyaning daromadga nisbati|Pulmatrix Inc (PULM) - Narxning daromadga nisbati|PTHL: Kapitalizatsiyaning sotish hajmiga nisbati|APM (Aptorum Group Ltd) - P/S multiplikatori|Lyra Therapeutics Inc (LYRA) - Narx/daromad koeffitsiyenti|P/S multiplikatori IBO|Kapitalizatsiyaning sotish hajmiga nisbati TNFA|cbdMD, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PRFX|Altamira Therapeutics Ltd. - P/S multiplikatori|LIPO: Narxning daromadga nisbati|OPTN: P/S multiplikatori|Narxning sotuvga nisbati PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - P/S multiplikatori|PTPI (Petros Pharmaceuticals Inc) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori QLI|SLRN - Sotuvga nisbatan narx|P/S multiplikatori TFFP (TFF Pharmaceuticals, Inc)